Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
278,657,526
-
Share change
-
-261,993
-
Total reported value
-
$11,152,427,420
-
Put/Call ratio
-
80%
-
Price per share
-
$40.02
-
Number of holders
-
785
-
Value change
-
-$13,000,558
-
Number of buys
-
326
-
Number of sells
-
365
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2019
As of 30 Jun 2019,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
785 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
278,657,526 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, ROYAL BANK OF CANADA, STATE STREET CORP, Black Creek Investment Management Inc., BANK OF AMERICA CORP /DE/, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This page lists
790
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.